Prescriptions for tirzepatide injections will not be available from GP surgeries or pharmacies in East and North Yorkshire – ...

Danish pharma giant Novo Nordisk on Tuesday launched its blockbuster weight loss drug Wegovy as a once-a-week injection in ...

Novo Nordisk has ended a partnership with telehealth company Him & Hers, after launching the collaboration less than two ...

The 0.25mg, 0.5mg and 1mg dosage of Wegovy will cost ₹17,345 for a month. A higher dose form of 1.75mg will cost ₹24,280 a month, while 2.4mg dose will be for ₹26,050. The drug follows a four-week ...

Wegovy is the first drug in India approved for both weight management and risk reduction of major adverse cardiovascular events in individuals with established heart disease.

Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, ...

Novo Nordisk has officially launched its anti-obesity drug Wegovy in India ahead of patent expiry. This move aims to tackle rising obesity rates while facing competition from rival drugs.

Mounjaro has been accessible in specialist NHS weight loss clinics since March. Another weight loss medication, Wegovy, also ...

Dr. Roach: What is the recommended daily protein allowance for older adults? I am in my 70s. — P.R.

While both drugs belong to the GLP-1 receptor agonist class, Mounjaro has a dual mechanism (GIP and GLP-1), which clinical ...

CHENNAI: Danish drugs and insulin maker Novo Nordisk launched Wegovy, its latest and the much-awaited weight-loss drug -- a once‑a‑week semaglutide injection, i ...